InvestorsHub Logo
Followers 0
Posts 1547
Boards Moderated 0
Alias Born 12/20/2003

Re: None

Monday, 12/13/2004 1:35:22 PM

Monday, December 13, 2004 1:35:22 PM

Post# of 346177
Can someone explain to me why we are doing Phase I at NABTT?

Dear Kimberly
While looking over your current protocols on the NABTT site, I noticed that the following had no description of what Phase it will be . Will this be a Phase I, II, or III trial? What is a dose confirmation study? Phase I? Thank you for any assistance.

Respectfully,

Terry

Protocols In Development *(Expanded Information Not Available)

o

An Open-label, Dose Confirmation and Dosimetry Study of Interstitial ^131 I-chTNT-1/B MAb (COTARA^TM ) For the Treatment of Glioblastoma Multiforme (GBM) at 1^st Relapse

REPLY

Protocol Development Coordinator
NABTT Central Office
Phone: 410-502-7425
Fax: 410-614-9335

Terry,

You are correct. A dose confirmation study is a Phase I study. The objective of this study is to find the safe dose for this drug.

Thanks,
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News